Oncology Institute Shares Outstanding 2020-2025 | TOI
Oncology Institute shares outstanding from 2020 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Oncology Institute Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 75 |
| 2023 | 74 |
| 2022 | 81 |
| 2021 | 66 |
| 2020 | 59 |
| 2019 | 5 |
|
Oncology Institute Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 97 |
| 2025-06-30 | 93 |
| 2025-03-31 | 77 |
| 2024-12-31 | 75 |
| 2024-09-30 | 76 |
| 2024-06-30 | 75 |
| 2024-03-31 | 74 |
| 2023-12-31 | 74 |
| 2023-09-30 | 73 |
| 2023-06-30 | 74 |
| 2023-03-31 | 73 |
| 2022-12-31 | 81 |
| 2022-09-30 | 80 |
| 2022-06-30 | 73 |
| 2022-03-31 | 76 |
| 2021-12-31 | 66 |
| 2021-09-30 | 66 |
| 2021-06-30 | 66 |
| 2021-03-31 | 63 |
| 2020-12-31 | 59 |
| 2020-09-30 | 6 |
| 2020-06-30 | 6 |
| 2020-03-31 | 5 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.347B | $0.393B |
| The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.388B | 30.55 |
| HCA Healthcare (HCA) | United States | $109.378B | 18.11 |
| CVS Health (CVS) | United States | $102.418B | 11.78 |
| Elevance Health (ELV) | United States | $82.379B | 12.08 |
| Cencora (COR) | United States | $67.098B | 21.63 |
| Natera (NTRA) | United States | $32.905B | 0.00 |
| DiDi Global (DIDIY) | China | $23.862B | 22.04 |
| Labcorp Holdings (LH) | United States | $21.055B | 16.05 |
| Medpace Holdings (MEDP) | United States | $17.138B | 42.55 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.432B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Viatris (VTRS) | United States | $15.399B | 5.74 |
| ICON (ICLR) | Ireland | $14.802B | 14.69 |
| Solventum (SOLV) | United States | $13.881B | 13.47 |
| Revvity (RVTY) | United States | $12.487B | 22.99 |
| CochLear (CHEOY) | Australia | $11.568B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.778B | 20.76 |
| Avantor (AVTR) | United States | $8.591B | 13.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.606B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.449B | 0.00 |
| HealthEquity (HQY) | United States | $7.201B | 26.93 |
| BrightSpring Health Services (BTSG) | United States | $6.965B | 41.53 |
| PACS (PACS) | United States | $6.598B | 40.12 |
| Bausch + Lomb (BLCO) | Canada | $6.181B | 40.58 |
| Sotera Health (SHC) | United States | $5.392B | 26.00 |
| Alignment Healthcare (ALHC) | United States | $4.186B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.175B | 55.76 |
| Concentras Parent (CON) | United States | $2.599B | 16.22 |
| Organon (OGN) | United States | $2.192B | 2.31 |
| Progyny (PGNY) | United States | $2.176B | 42.78 |
| Surgery Partners (SGRY) | United States | $2.080B | 26.80 |
| Pediatrix Medical (MD) | United States | $1.904B | 11.37 |
| Establishment Labs Holdings (ESTA) | United States | $1.893B | 0.00 |
| Ardent Health (ARDT) | United States | $1.266B | 4.13 |
| Teladoc Health (TDOC) | United States | $1.241B | 0.00 |
| Nutex Health (NUTX) | United States | $1.221B | 9.33 |
| CareDx (CDNA) | United States | $1.038B | 16.97 |
| GoodRx Holdings (GDRX) | United States | $0.971B | 15.89 |
| Omada Health (OMDA) | United States | $0.934B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.750B | 4.26 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.708B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| Enhabit (EHAB) | United States | $0.554B | 24.89 |
| CryoPort (CYRX) | United States | $0.538B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.466B | 0.00 |
| SBC Medicals (SBC) | United States | $0.457B | 8.42 |
| Agilon Health (AGL) | United States | $0.394B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.349B | 5.62 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.280B | 0.00 |
| So-Young (SY) | China | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.204B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.085B | 0.00 |
| Biodesix (BDSX) | United States | $0.079B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |